Research Article
Prognostic Nomograms for Nonelderly Adults with Gastric Signet Ring Cell Carcinoma
Table 2
Univariate and multivariate Cox analysis of the determinants of overall survival (OS) of patients with gastric signet ring cell carcinoma (GSRC).
| Variables | Univariate analysis | Multivariate analysis | HR (95% CI) | value | HR (95% CI) | value |
| Age at diagnose (years) | | | | | 18-44 | 1 | | | | 45-64 | 1.118 (0.937-1.334) | 0.215 | | | Race | | | | | Black | 1 | | 1 | | Other | 0.672 (0.517-0.873) | 0.003 | 0.658 (0.501-0.864) | 0.003 | White | 0.948 (0.765-1.174) | 0.624 | 0.870 (0.694-1.090) | 0.226 | Sex | | | | | Female | 1 | | | | Male | 0.974 (0.840-1.129) | 0.722 | | | Marital status | | | | | Married | 1 | | 1 | | Unmarried | 1.210 (1.036-1.412) | 0.016 | 1.108 (0.943-1.301) | 0.214 | Primary site | | | | | Proximal third (cardia and fundus) | 1 | | 1 | | Mid third (body and lesser curvature) | 0.741 (0.588-0.934) | 0.011 | 0.815 (0.642-1.035) | 0.094 | Distal third (antrum and pylorus) | 0.882 (0.713-1.092) | 0.249 | 0.831 (0.664-1.040) | 0.106 | Greater curvature | 0.932 (0.661-1.313) | 0.687 | 0.887 (0.625-1.258) | 0.500 | Overlapping lesions | 1.314 (1.012-1.705) | 0.040 | 0.808 (0.613-1.065) | 0.130 | NOS | 0.985 (0.712-1.362) | 0.927 | 0.870 (0.623-1.215) | 0.413 | Grade | | | | | Moderately differentiated (II) | 1 | | | | Poorly differentiated (III) | 1.230 (0.695-2.178) | 0.477 | | | Undifferentiated (IV) | 1.362 (0.701-2.645) | 0.362 | | | T stage | | | | | T1 | 1 | | 1 | | T2 | 2.624 (1.598-4.310) | <0.001 | 2.562 (1.534-4.278) | <0.001 | T3 | 5.877 (3.951-8.740) | <0.001 | 4.668 (3.028-7.195) | <0.001 | T4 | 11.257 (7.604-16.670) | <0.001 | 7.353 (4.740-11.406) | <0.001 | N stage | | | | | N0 | 1 | | 1 | | N1 | 2.189 (1.678-2.854) | <0.001 | 1.327 (1.001-1.759) | 0.049 | N2 | 2.689 (2.091-3.458) | <0.001 | 1.528 (1.166-2.002) | 0.002 | N3 | 4.496 (3.580-5.647) | <0.001 | 1.724 (1.312-2.265) | <0.001 | M stage | | | | | M0 | 1 | | 1 | | M1 | 3.547 (2.958-4.254) | <0.001 | 2.113 (1.746-2.557) | <0.001 | Tumor size (cm) | | | | | ≤5 | 1 | | 1 | | >5 | 2.338 (2.010-2.720) | <0.001 | 1.276 (1.082-1.504) | 0.004 | PLNE | | | | | <15 | 1 | | 1 | | ≥15 | 2.800 (2.335-3.357) | <0.001 | 1.418 (1.135-1.771) | 0.002 | Radiation | | | | | No/unknown | 1 | | | | Yes | 0.909 (0.784-1.055) | 0.211 | | | Chemotherapy | | | | | No/unknown | 1 | | 1 | | Yes | 1.399 (1.176-1.666) | <0.001 | 0.669 (0.555-0.807) | <0.001 | Year of diagnose | 0.964 (0.942-0.987) | 0.002 | 1.000 (0.976-1.025) | 0.987 |
|
|
HR: hazard ratio; CI: confidence interval; PLNE: number of positive lymph nodes.
|